BD opens facility in Hungary; ConforMIS gets EU approval for knee-replacement device;

> BD (Becton, Dickinson and Company), a leading global medical technology company, today celebrated the grand opening of its new production facility in Tatabánya, Hungary. Release

> ConforMIS announced today that its customizable knee-replacement product has been approved by European regulators. Report

> TYRX has released AIGISRxFlat, an antibacterial product that helps provide protection against infections associated with implanted pacemakers and defibrillators. Release

> Less-invasive "valve-in-valve" implants may help repair prosthetic animal-tissue heart valves in people who are not healthy enough to undergo a second open heart surgery, a study shows. Report

> Fast-moving Galway medical devices developer Crospon has launched its EndoFLIP product, which received FDA clearance in December, into the lucrative US healthcare market. Report

> Micralyne has been certified to ISO 13485, reinforcing Micralyne's position as a leading enabler for medical companies requiring advanced BioMEMS and microfluidic devices. Report

And Finally... Although printing organs and tissues may sound like science fiction, Wake Forest researchers have developed a device akin to the an office inkjet printer that can spray skin cells directly onto burn victims, quickly protecting the wound and serving as an alternative to skin grafts. Story

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.